nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Temozolomide—brain cancer	0.098	0.487	CbGbCtD
Brinzolamide—CYP3A4—Lomustine—brain cancer	0.0833	0.414	CbGbCtD
Brinzolamide—Dorzolamide—CYP2C9—brain cancer	0.0312	1	CrCbGaD
Brinzolamide—CYP3A4—Etoposide—brain cancer	0.0201	0.1	CbGbCtD
Brinzolamide—CA4—ganglion—brain cancer	0.00991	0.0465	CbGeAlD
Brinzolamide—CA5A—endocrine gland—brain cancer	0.00901	0.0423	CbGeAlD
Brinzolamide—Digestion impaired—Hydroxyurea—brain cancer	0.00808	0.0146	CcSEcCtD
Brinzolamide—CA14—telencephalon—brain cancer	0.00792	0.0372	CbGeAlD
Brinzolamide—CA4—hindbrain—brain cancer	0.00752	0.0353	CbGeAlD
Brinzolamide—Visual acuity reduced—Temozolomide—brain cancer	0.00709	0.0128	CcSEcCtD
Brinzolamide—CA7—midbrain—brain cancer	0.00683	0.032	CbGeAlD
Brinzolamide—Nightmare—Procarbazine—brain cancer	0.00674	0.0122	CcSEcCtD
Brinzolamide—Photophobia—Procarbazine—brain cancer	0.00655	0.0118	CcSEcCtD
Brinzolamide—Digestion impaired—Temozolomide—brain cancer	0.00631	0.0114	CcSEcCtD
Brinzolamide—CA2—hindbrain—brain cancer	0.00623	0.0292	CbGeAlD
Brinzolamide—CA14—medulla oblongata—brain cancer	0.00622	0.0292	CbGeAlD
Brinzolamide—CA12—telencephalon—brain cancer	0.00617	0.029	CbGeAlD
Brinzolamide—Apathy—Temozolomide—brain cancer	0.0059	0.0107	CcSEcCtD
Brinzolamide—Flat affect—Temozolomide—brain cancer	0.00585	0.0106	CcSEcCtD
Brinzolamide—CA6—head—brain cancer	0.00573	0.0269	CbGeAlD
Brinzolamide—CA14—midbrain—brain cancer	0.00569	0.0267	CbGeAlD
Brinzolamide—CA14—spinal cord—brain cancer	0.00555	0.026	CbGeAlD
Brinzolamide—Memory impairment—Temozolomide—brain cancer	0.00537	0.00969	CcSEcCtD
Brinzolamide—Visual impairment—Lomustine—brain cancer	0.00532	0.00959	CcSEcCtD
Brinzolamide—CA7—cerebellum—brain cancer	0.00528	0.0248	CbGeAlD
Brinzolamide—CA9—endocrine gland—brain cancer	0.00526	0.0247	CbGeAlD
Brinzolamide—Diplopia—Procarbazine—brain cancer	0.00506	0.00914	CcSEcCtD
Brinzolamide—Rash maculo-papular—Hydroxyurea—brain cancer	0.00491	0.00885	CcSEcCtD
Brinzolamide—CA1—telencephalon—brain cancer	0.00489	0.023	CbGeAlD
Brinzolamide—Alopecia—Lomustine—brain cancer	0.00488	0.0088	CcSEcCtD
Brinzolamide—CA9—cerebellum—brain cancer	0.00464	0.0218	CbGeAlD
Brinzolamide—CA5B—gonad—brain cancer	0.00462	0.0217	CbGeAlD
Brinzolamide—Infection—Carboplatin—brain cancer	0.00445	0.00803	CcSEcCtD
Brinzolamide—CA14—cerebellum—brain cancer	0.0044	0.0206	CbGeAlD
Brinzolamide—CA4—brainstem—brain cancer	0.00431	0.0202	CbGeAlD
Brinzolamide—CA7—brain—brain cancer	0.00429	0.0201	CbGeAlD
Brinzolamide—Angina pectoris—Procarbazine—brain cancer	0.00426	0.00769	CcSEcCtD
Brinzolamide—Pollakiuria—Procarbazine—brain cancer	0.00404	0.00729	CcSEcCtD
Brinzolamide—Dry eye—Temozolomide—brain cancer	0.0039	0.00703	CcSEcCtD
Brinzolamide—CA12—endocrine gland—brain cancer	0.00389	0.0183	CbGeAlD
Brinzolamide—Infection—Lomustine—brain cancer	0.00389	0.00703	CcSEcCtD
Brinzolamide—CA12—head—brain cancer	0.00384	0.018	CbGeAlD
Brinzolamide—Pain—Carboplatin—brain cancer	0.00383	0.00691	CcSEcCtD
Brinzolamide—CA4—telencephalon—brain cancer	0.00382	0.0179	CbGeAlD
Brinzolamide—Chest discomfort—Etoposide—brain cancer	0.00381	0.00688	CcSEcCtD
Brinzolamide—Abnormal vision—Carmustine—brain cancer	0.00381	0.00687	CcSEcCtD
Brinzolamide—Epistaxis—Procarbazine—brain cancer	0.00368	0.00664	CcSEcCtD
Brinzolamide—Abnormal vision—Temozolomide—brain cancer	0.00368	0.00664	CcSEcCtD
Brinzolamide—CA14—brain—brain cancer	0.00357	0.0168	CbGeAlD
Brinzolamide—CA2—brainstem—brain cancer	0.00357	0.0168	CbGeAlD
Brinzolamide—Breast disorder—Hydroxyurea—brain cancer	0.00354	0.00639	CcSEcCtD
Brinzolamide—CA12—central nervous system—brain cancer	0.00351	0.0165	CbGeAlD
Brinzolamide—Eye pain—Carmustine—brain cancer	0.00351	0.00633	CcSEcCtD
Brinzolamide—CA5B—endocrine gland—brain cancer	0.00349	0.0164	CbGeAlD
Brinzolamide—CA5B—head—brain cancer	0.00345	0.0162	CbGeAlD
Brinzolamide—CA1—spinal cord—brain cancer	0.00343	0.0161	CbGeAlD
Brinzolamide—Decreased appetite—Lomustine—brain cancer	0.00341	0.00615	CcSEcCtD
Brinzolamide—Eye pain—Temozolomide—brain cancer	0.00339	0.00612	CcSEcCtD
Brinzolamide—Amnesia—Carmustine—brain cancer	0.00337	0.00608	CcSEcCtD
Brinzolamide—Nasal congestion—Temozolomide—brain cancer	0.00336	0.00606	CcSEcCtD
Brinzolamide—Amnesia—Temozolomide—brain cancer	0.00326	0.00588	CcSEcCtD
Brinzolamide—CA2—telencephalon—brain cancer	0.00317	0.0149	CbGeAlD
Brinzolamide—Diplopia—Carmustine—brain cancer	0.00317	0.00572	CcSEcCtD
Brinzolamide—CA5B—central nervous system—brain cancer	0.00315	0.0148	CbGeAlD
Brinzolamide—Arrhythmia—Procarbazine—brain cancer	0.00313	0.00565	CcSEcCtD
Brinzolamide—CA4—pituitary gland—brain cancer	0.00311	0.0146	CbGeAlD
Brinzolamide—Alopecia—Procarbazine—brain cancer	0.0031	0.00558	CcSEcCtD
Brinzolamide—CA1—endocrine gland—brain cancer	0.00309	0.0145	CbGeAlD
Brinzolamide—Oesophagitis—Etoposide—brain cancer	0.00308	0.00556	CcSEcCtD
Brinzolamide—Rash maculo-papular—Etoposide—brain cancer	0.00307	0.00553	CcSEcCtD
Brinzolamide—Diplopia—Temozolomide—brain cancer	0.00306	0.00552	CcSEcCtD
Brinzolamide—CA1—head—brain cancer	0.00305	0.0143	CbGeAlD
Brinzolamide—Infestation—Hydroxyurea—brain cancer	0.00302	0.00545	CcSEcCtD
Brinzolamide—Infestation NOS—Hydroxyurea—brain cancer	0.00302	0.00545	CcSEcCtD
Brinzolamide—CA4—medulla oblongata—brain cancer	0.003	0.0141	CbGeAlD
Brinzolamide—Tension—Procarbazine—brain cancer	0.00299	0.0054	CcSEcCtD
Brinzolamide—Nervousness—Procarbazine—brain cancer	0.00296	0.00534	CcSEcCtD
Brinzolamide—Liver function test abnormal—Carmustine—brain cancer	0.00292	0.00528	CcSEcCtD
Brinzolamide—Tremor—Procarbazine—brain cancer	0.00286	0.00515	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00286	0.00515	CcSEcCtD
Brinzolamide—CA12—brain—brain cancer	0.00279	0.0131	CbGeAlD
Brinzolamide—CA1—central nervous system—brain cancer	0.00278	0.013	CbGeAlD
Brinzolamide—Breast disorder—Temozolomide—brain cancer	0.00277	0.00499	CcSEcCtD
Brinzolamide—CA4—midbrain—brain cancer	0.00275	0.0129	CbGeAlD
Brinzolamide—CA4—spinal cord—brain cancer	0.00268	0.0126	CbGeAlD
Brinzolamide—Cough—Procarbazine—brain cancer	0.00266	0.0048	CcSEcCtD
Brinzolamide—Hypertension—Procarbazine—brain cancer	0.00263	0.00475	CcSEcCtD
Brinzolamide—Myalgia—Procarbazine—brain cancer	0.0026	0.00468	CcSEcCtD
Brinzolamide—Arthralgia—Procarbazine—brain cancer	0.0026	0.00468	CcSEcCtD
Brinzolamide—CA2—pituitary gland—brain cancer	0.00258	0.0121	CbGeAlD
Brinzolamide—Bronchitis—Temozolomide—brain cancer	0.00254	0.00459	CcSEcCtD
Brinzolamide—Dry mouth—Procarbazine—brain cancer	0.00254	0.00458	CcSEcCtD
Brinzolamide—CA5B—brain—brain cancer	0.0025	0.0117	CbGeAlD
Brinzolamide—Vomiting—Lomustine—brain cancer	0.00249	0.0045	CcSEcCtD
Brinzolamide—CA2—medulla oblongata—brain cancer	0.00249	0.0117	CbGeAlD
Brinzolamide—Infection—Procarbazine—brain cancer	0.00247	0.00446	CcSEcCtD
Brinzolamide—Angiopathy—Hydroxyurea—brain cancer	0.00246	0.00444	CcSEcCtD
Brinzolamide—Pollakiuria—Temozolomide—brain cancer	0.00244	0.00441	CcSEcCtD
Brinzolamide—Erectile dysfunction—Temozolomide—brain cancer	0.00244	0.0044	CcSEcCtD
Brinzolamide—Depression—Carmustine—brain cancer	0.00243	0.00439	CcSEcCtD
Brinzolamide—Tachycardia—Procarbazine—brain cancer	0.00243	0.00438	CcSEcCtD
Brinzolamide—CA4—endocrine gland—brain cancer	0.00241	0.0113	CbGeAlD
Brinzolamide—Alopecia—Hydroxyurea—brain cancer	0.0024	0.00432	CcSEcCtD
Brinzolamide—CA4—head—brain cancer	0.00238	0.0112	CbGeAlD
Brinzolamide—Erythema—Hydroxyurea—brain cancer	0.00236	0.00426	CcSEcCtD
Brinzolamide—Infestation—Temozolomide—brain cancer	0.00236	0.00426	CcSEcCtD
Brinzolamide—Infestation NOS—Temozolomide—brain cancer	0.00236	0.00426	CcSEcCtD
Brinzolamide—Depression—Temozolomide—brain cancer	0.00235	0.00424	CcSEcCtD
Brinzolamide—Nausea—Lomustine—brain cancer	0.00233	0.0042	CcSEcCtD
Brinzolamide—Hypotension—Procarbazine—brain cancer	0.00233	0.0042	CcSEcCtD
Brinzolamide—CA2—midbrain—brain cancer	0.00228	0.0107	CbGeAlD
Brinzolamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00227	0.00409	CcSEcCtD
Brinzolamide—Insomnia—Procarbazine—brain cancer	0.00225	0.00406	CcSEcCtD
Brinzolamide—Paraesthesia—Procarbazine—brain cancer	0.00223	0.00403	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Temozolomide—brain cancer	0.00223	0.00403	CcSEcCtD
Brinzolamide—CA2—spinal cord—brain cancer	0.00222	0.0104	CbGeAlD
Brinzolamide—Sinusitis—Temozolomide—brain cancer	0.00221	0.00399	CcSEcCtD
Brinzolamide—Somnolence—Procarbazine—brain cancer	0.00221	0.00399	CcSEcCtD
Brinzolamide—CA1—brain—brain cancer	0.00221	0.0104	CbGeAlD
Brinzolamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.00219	0.00395	CcSEcCtD
Brinzolamide—Hypoaesthesia—Carmustine—brain cancer	0.00218	0.00393	CcSEcCtD
Brinzolamide—CA4—central nervous system—brain cancer	0.00217	0.0102	CbGeAlD
Brinzolamide—Decreased appetite—Procarbazine—brain cancer	0.00216	0.0039	CcSEcCtD
Brinzolamide—Oedema peripheral—Carmustine—brain cancer	0.00216	0.0039	CcSEcCtD
Brinzolamide—Connective tissue disorder—Carmustine—brain cancer	0.00215	0.00389	CcSEcCtD
Brinzolamide—Fatigue—Procarbazine—brain cancer	0.00215	0.00387	CcSEcCtD
Brinzolamide—Malaise—Hydroxyurea—brain cancer	0.00213	0.00384	CcSEcCtD
Brinzolamide—Pain—Procarbazine—brain cancer	0.00213	0.00384	CcSEcCtD
Brinzolamide—CA4—cerebellum—brain cancer	0.00212	0.00997	CbGeAlD
Brinzolamide—Visual impairment—Carmustine—brain cancer	0.00211	0.00381	CcSEcCtD
Brinzolamide—Hypoaesthesia—Temozolomide—brain cancer	0.00211	0.0038	CcSEcCtD
Brinzolamide—Pharyngitis—Temozolomide—brain cancer	0.0021	0.00379	CcSEcCtD
Brinzolamide—Urinary tract disorder—Temozolomide—brain cancer	0.00209	0.00377	CcSEcCtD
Brinzolamide—Oedema peripheral—Temozolomide—brain cancer	0.00209	0.00376	CcSEcCtD
Brinzolamide—Connective tissue disorder—Temozolomide—brain cancer	0.00208	0.00375	CcSEcCtD
Brinzolamide—Urethral disorder—Temozolomide—brain cancer	0.00208	0.00375	CcSEcCtD
Brinzolamide—Feeling abnormal—Procarbazine—brain cancer	0.00205	0.0037	CcSEcCtD
Brinzolamide—Eye disorder—Carmustine—brain cancer	0.00205	0.0037	CcSEcCtD
Brinzolamide—Visual impairment—Temozolomide—brain cancer	0.00204	0.00368	CcSEcCtD
Brinzolamide—CA2—endocrine gland—brain cancer	0.002	0.00938	CbGeAlD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.002	0.0036	CcSEcCtD
Brinzolamide—Discomfort—Hydroxyurea—brain cancer	0.00199	0.00358	CcSEcCtD
Brinzolamide—Eye disorder—Temozolomide—brain cancer	0.00198	0.00357	CcSEcCtD
Brinzolamide—Urticaria—Procarbazine—brain cancer	0.00198	0.00357	CcSEcCtD
Brinzolamide—Tinnitus—Temozolomide—brain cancer	0.00197	0.00356	CcSEcCtD
Brinzolamide—CA2—head—brain cancer	0.00197	0.00926	CbGeAlD
Brinzolamide—Cardiac disorder—Temozolomide—brain cancer	0.00197	0.00355	CcSEcCtD
Brinzolamide—Arrhythmia—Carmustine—brain cancer	0.00196	0.00353	CcSEcCtD
Brinzolamide—Alopecia—Carmustine—brain cancer	0.00194	0.00349	CcSEcCtD
Brinzolamide—Angiopathy—Temozolomide—brain cancer	0.00192	0.00347	CcSEcCtD
Brinzolamide—Mental disorder—Carmustine—brain cancer	0.00192	0.00346	CcSEcCtD
Brinzolamide—Infection—Hydroxyurea—brain cancer	0.00191	0.00345	CcSEcCtD
Brinzolamide—Immune system disorder—Temozolomide—brain cancer	0.00191	0.00345	CcSEcCtD
Brinzolamide—Mediastinal disorder—Temozolomide—brain cancer	0.00191	0.00344	CcSEcCtD
Brinzolamide—Erythema—Carmustine—brain cancer	0.00191	0.00344	CcSEcCtD
Brinzolamide—Malnutrition—Carmustine—brain cancer	0.00191	0.00344	CcSEcCtD
Brinzolamide—Nervous system disorder—Hydroxyurea—brain cancer	0.00189	0.00341	CcSEcCtD
Brinzolamide—Infestation NOS—Etoposide—brain cancer	0.00189	0.00341	CcSEcCtD
Brinzolamide—Infestation—Etoposide—brain cancer	0.00189	0.00341	CcSEcCtD
Brinzolamide—Alopecia—Temozolomide—brain cancer	0.00187	0.00338	CcSEcCtD
Brinzolamide—Skin disorder—Hydroxyurea—brain cancer	0.00187	0.00338	CcSEcCtD
Brinzolamide—Mental disorder—Temozolomide—brain cancer	0.00186	0.00335	CcSEcCtD
Brinzolamide—Back pain—Carmustine—brain cancer	0.00185	0.00333	CcSEcCtD
Brinzolamide—Erythema—Temozolomide—brain cancer	0.00184	0.00333	CcSEcCtD
Brinzolamide—Malnutrition—Temozolomide—brain cancer	0.00184	0.00333	CcSEcCtD
Brinzolamide—Hypersensitivity—Procarbazine—brain cancer	0.00183	0.00331	CcSEcCtD
Brinzolamide—Dysgeusia—Temozolomide—brain cancer	0.00181	0.00326	CcSEcCtD
Brinzolamide—CA2—central nervous system—brain cancer	0.0018	0.00846	CbGeAlD
Brinzolamide—Vision blurred—Carmustine—brain cancer	0.0018	0.00324	CcSEcCtD
Brinzolamide—Tremor—Carmustine—brain cancer	0.00179	0.00322	CcSEcCtD
Brinzolamide—Asthenia—Procarbazine—brain cancer	0.00179	0.00322	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Etoposide—brain cancer	0.00179	0.00322	CcSEcCtD
Brinzolamide—Back pain—Temozolomide—brain cancer	0.00178	0.00322	CcSEcCtD
Brinzolamide—CA2—cerebellum—brain cancer	0.00176	0.00826	CbGeAlD
Brinzolamide—Pruritus—Procarbazine—brain cancer	0.00176	0.00318	CcSEcCtD
Brinzolamide—Agitation—Carmustine—brain cancer	0.00175	0.00316	CcSEcCtD
Brinzolamide—Vision blurred—Temozolomide—brain cancer	0.00174	0.00313	CcSEcCtD
Brinzolamide—Tremor—Temozolomide—brain cancer	0.00173	0.00312	CcSEcCtD
Brinzolamide—CA4—brain—brain cancer	0.00173	0.0081	CbGeAlD
Brinzolamide—Dyspnoea—Hydroxyurea—brain cancer	0.00172	0.0031	CcSEcCtD
Brinzolamide—Somnolence—Hydroxyurea—brain cancer	0.00171	0.00309	CcSEcCtD
Brinzolamide—Ill-defined disorder—Temozolomide—brain cancer	0.00171	0.00309	CcSEcCtD
Brinzolamide—Diarrhoea—Procarbazine—brain cancer	0.0017	0.00307	CcSEcCtD
Brinzolamide—Dyspepsia—Hydroxyurea—brain cancer	0.0017	0.00306	CcSEcCtD
Brinzolamide—Agitation—Temozolomide—brain cancer	0.00169	0.00306	CcSEcCtD
Brinzolamide—Hypoaesthesia—Etoposide—brain cancer	0.00169	0.00304	CcSEcCtD
Brinzolamide—Decreased appetite—Hydroxyurea—brain cancer	0.00167	0.00302	CcSEcCtD
Brinzolamide—Urinary tract disorder—Etoposide—brain cancer	0.00167	0.00302	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00166	0.003	CcSEcCtD
Brinzolamide—Malaise—Temozolomide—brain cancer	0.00166	0.003	CcSEcCtD
Brinzolamide—Urethral disorder—Etoposide—brain cancer	0.00166	0.003	CcSEcCtD
Brinzolamide—Fatigue—Hydroxyurea—brain cancer	0.00166	0.003	CcSEcCtD
Brinzolamide—Vertigo—Temozolomide—brain cancer	0.00166	0.00299	CcSEcCtD
Brinzolamide—Hypertension—Carmustine—brain cancer	0.00165	0.00297	CcSEcCtD
Brinzolamide—Pain—Hydroxyurea—brain cancer	0.00165	0.00297	CcSEcCtD
Brinzolamide—Dizziness—Procarbazine—brain cancer	0.00165	0.00297	CcSEcCtD
Brinzolamide—Palpitations—Temozolomide—brain cancer	0.00163	0.00294	CcSEcCtD
Brinzolamide—Myalgia—Carmustine—brain cancer	0.00162	0.00293	CcSEcCtD
Brinzolamide—Chest pain—Carmustine—brain cancer	0.00162	0.00293	CcSEcCtD
Brinzolamide—Cough—Temozolomide—brain cancer	0.00161	0.0029	CcSEcCtD
Brinzolamide—Hypertension—Temozolomide—brain cancer	0.00159	0.00287	CcSEcCtD
Brinzolamide—Feeling abnormal—Hydroxyurea—brain cancer	0.00159	0.00286	CcSEcCtD
Brinzolamide—Eye disorder—Etoposide—brain cancer	0.00158	0.00286	CcSEcCtD
Brinzolamide—Vomiting—Procarbazine—brain cancer	0.00158	0.00285	CcSEcCtD
Brinzolamide—Cardiac disorder—Etoposide—brain cancer	0.00157	0.00284	CcSEcCtD
Brinzolamide—Arthralgia—Temozolomide—brain cancer	0.00157	0.00283	CcSEcCtD
Brinzolamide—Myalgia—Temozolomide—brain cancer	0.00157	0.00283	CcSEcCtD
Brinzolamide—Rash—Procarbazine—brain cancer	0.00157	0.00283	CcSEcCtD
Brinzolamide—Dermatitis—Procarbazine—brain cancer	0.00157	0.00283	CcSEcCtD
Brinzolamide—Headache—Procarbazine—brain cancer	0.00156	0.00281	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00156	0.00281	CcSEcCtD
Brinzolamide—Discomfort—Temozolomide—brain cancer	0.00155	0.0028	CcSEcCtD
Brinzolamide—Infection—Carmustine—brain cancer	0.00155	0.00279	CcSEcCtD
Brinzolamide—Angiopathy—Etoposide—brain cancer	0.00154	0.00277	CcSEcCtD
Brinzolamide—Dry mouth—Temozolomide—brain cancer	0.00153	0.00277	CcSEcCtD
Brinzolamide—Immune system disorder—Etoposide—brain cancer	0.00153	0.00276	CcSEcCtD
Brinzolamide—Mediastinal disorder—Etoposide—brain cancer	0.00153	0.00276	CcSEcCtD
Brinzolamide—Tachycardia—Carmustine—brain cancer	0.00152	0.00274	CcSEcCtD
Brinzolamide—Alopecia—Etoposide—brain cancer	0.0015	0.0027	CcSEcCtD
Brinzolamide—Infection—Temozolomide—brain cancer	0.00149	0.0027	CcSEcCtD
Brinzolamide—Nausea—Procarbazine—brain cancer	0.00148	0.00267	CcSEcCtD
Brinzolamide—Nervous system disorder—Temozolomide—brain cancer	0.00148	0.00266	CcSEcCtD
Brinzolamide—Skin disorder—Temozolomide—brain cancer	0.00146	0.00264	CcSEcCtD
Brinzolamide—Hypotension—Carmustine—brain cancer	0.00145	0.00262	CcSEcCtD
Brinzolamide—Dysgeusia—Etoposide—brain cancer	0.00144	0.00261	CcSEcCtD
Brinzolamide—CA2—brain—brain cancer	0.00143	0.00671	CbGeAlD
Brinzolamide—Back pain—Etoposide—brain cancer	0.00143	0.00257	CcSEcCtD
Brinzolamide—Hypersensitivity—Hydroxyurea—brain cancer	0.00142	0.00256	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.00142	0.00256	CcSEcCtD
Brinzolamide—Muscle spasms—Etoposide—brain cancer	0.00142	0.00256	CcSEcCtD
Brinzolamide—Insomnia—Carmustine—brain cancer	0.00141	0.00254	CcSEcCtD
Brinzolamide—Paraesthesia—Carmustine—brain cancer	0.0014	0.00252	CcSEcCtD
Brinzolamide—Dyspnoea—Carmustine—brain cancer	0.00139	0.0025	CcSEcCtD
Brinzolamide—Somnolence—Carmustine—brain cancer	0.00138	0.0025	CcSEcCtD
Brinzolamide—Asthenia—Hydroxyurea—brain cancer	0.00138	0.00249	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00137	0.00247	CcSEcCtD
Brinzolamide—Ill-defined disorder—Etoposide—brain cancer	0.00137	0.00247	CcSEcCtD
Brinzolamide—Insomnia—Temozolomide—brain cancer	0.00136	0.00246	CcSEcCtD
Brinzolamide—Decreased appetite—Carmustine—brain cancer	0.00135	0.00244	CcSEcCtD
Brinzolamide—Paraesthesia—Temozolomide—brain cancer	0.00135	0.00244	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Carmustine—brain cancer	0.00134	0.00243	CcSEcCtD
Brinzolamide—Dyspnoea—Temozolomide—brain cancer	0.00134	0.00242	CcSEcCtD
Brinzolamide—Somnolence—Temozolomide—brain cancer	0.00134	0.00241	CcSEcCtD
Brinzolamide—Pain—Carmustine—brain cancer	0.00133	0.0024	CcSEcCtD
Brinzolamide—Malaise—Etoposide—brain cancer	0.00133	0.0024	CcSEcCtD
Brinzolamide—Vertigo—Etoposide—brain cancer	0.00133	0.00239	CcSEcCtD
Brinzolamide—Dyspepsia—Temozolomide—brain cancer	0.00132	0.00239	CcSEcCtD
Brinzolamide—Diarrhoea—Hydroxyurea—brain cancer	0.00132	0.00238	CcSEcCtD
Brinzolamide—Decreased appetite—Temozolomide—brain cancer	0.00131	0.00236	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.0013	0.00234	CcSEcCtD
Brinzolamide—Fatigue—Temozolomide—brain cancer	0.0013	0.00234	CcSEcCtD
Brinzolamide—CYP3A4—endocrine gland—brain cancer	0.00129	0.00605	CbGeAlD
Brinzolamide—Cough—Etoposide—brain cancer	0.00129	0.00232	CcSEcCtD
Brinzolamide—Pain—Temozolomide—brain cancer	0.00129	0.00232	CcSEcCtD
Brinzolamide—Feeling abnormal—Carmustine—brain cancer	0.00128	0.00231	CcSEcCtD
Brinzolamide—Hypertension—Etoposide—brain cancer	0.00127	0.0023	CcSEcCtD
Brinzolamide—Dizziness—Hydroxyurea—brain cancer	0.00127	0.0023	CcSEcCtD
Brinzolamide—Chest pain—Etoposide—brain cancer	0.00126	0.00227	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00125	0.00225	CcSEcCtD
Brinzolamide—Discomfort—Etoposide—brain cancer	0.00124	0.00224	CcSEcCtD
Brinzolamide—Feeling abnormal—Temozolomide—brain cancer	0.00124	0.00224	CcSEcCtD
Brinzolamide—Vomiting—Hydroxyurea—brain cancer	0.00122	0.00221	CcSEcCtD
Brinzolamide—Rash—Hydroxyurea—brain cancer	0.00121	0.00219	CcSEcCtD
Brinzolamide—Dermatitis—Hydroxyurea—brain cancer	0.00121	0.00219	CcSEcCtD
Brinzolamide—Headache—Hydroxyurea—brain cancer	0.00121	0.00218	CcSEcCtD
Brinzolamide—Infection—Etoposide—brain cancer	0.0012	0.00216	CcSEcCtD
Brinzolamide—Urticaria—Temozolomide—brain cancer	0.0012	0.00216	CcSEcCtD
Brinzolamide—Tachycardia—Etoposide—brain cancer	0.00118	0.00212	CcSEcCtD
Brinzolamide—Skin disorder—Etoposide—brain cancer	0.00117	0.00211	CcSEcCtD
Brinzolamide—CYP3A4—central nervous system—brain cancer	0.00116	0.00546	CbGeAlD
Brinzolamide—Hypersensitivity—Carmustine—brain cancer	0.00115	0.00207	CcSEcCtD
Brinzolamide—Nausea—Hydroxyurea—brain cancer	0.00114	0.00206	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—brain cancer	0.00113	0.00203	CcSEcCtD
Brinzolamide—Asthenia—Carmustine—brain cancer	0.00112	0.00202	CcSEcCtD
Brinzolamide—Hypersensitivity—Temozolomide—brain cancer	0.00111	0.002	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—brain cancer	0.00108	0.00195	CcSEcCtD
Brinzolamide—Asthenia—Temozolomide—brain cancer	0.00108	0.00195	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—brain cancer	0.00107	0.00194	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—brain cancer	0.00107	0.00193	CcSEcCtD
Brinzolamide—Diarrhoea—Carmustine—brain cancer	0.00107	0.00192	CcSEcCtD
Brinzolamide—Pruritus—Temozolomide—brain cancer	0.00106	0.00192	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—brain cancer	0.00105	0.00189	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—brain cancer	0.00104	0.00188	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—brain cancer	0.00104	0.00187	CcSEcCtD
Brinzolamide—Dizziness—Carmustine—brain cancer	0.00103	0.00186	CcSEcCtD
Brinzolamide—Pain—Etoposide—brain cancer	0.00103	0.00186	CcSEcCtD
Brinzolamide—Diarrhoea—Temozolomide—brain cancer	0.00103	0.00186	CcSEcCtD
Brinzolamide—Dizziness—Temozolomide—brain cancer	0.000995	0.0018	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—brain cancer	0.000992	0.00179	CcSEcCtD
Brinzolamide—Vomiting—Carmustine—brain cancer	0.00099	0.00179	CcSEcCtD
Brinzolamide—Rash—Carmustine—brain cancer	0.000982	0.00177	CcSEcCtD
Brinzolamide—Dermatitis—Carmustine—brain cancer	0.000981	0.00177	CcSEcCtD
Brinzolamide—Headache—Carmustine—brain cancer	0.000975	0.00176	CcSEcCtD
Brinzolamide—Vomiting—Temozolomide—brain cancer	0.000957	0.00173	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—brain cancer	0.000956	0.00173	CcSEcCtD
Brinzolamide—Rash—Temozolomide—brain cancer	0.000949	0.00171	CcSEcCtD
Brinzolamide—Dermatitis—Temozolomide—brain cancer	0.000948	0.00171	CcSEcCtD
Brinzolamide—Headache—Temozolomide—brain cancer	0.000943	0.0017	CcSEcCtD
Brinzolamide—Nausea—Carmustine—brain cancer	0.000925	0.00167	CcSEcCtD
Brinzolamide—Nausea—Temozolomide—brain cancer	0.000894	0.00161	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—brain cancer	0.000887	0.0016	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—brain cancer	0.000864	0.00156	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—brain cancer	0.000852	0.00154	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—brain cancer	0.000824	0.00149	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—brain cancer	0.000796	0.00144	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—brain cancer	0.000766	0.00138	CcSEcCtD
Brinzolamide—Rash—Etoposide—brain cancer	0.000759	0.00137	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—brain cancer	0.000758	0.00137	CcSEcCtD
Brinzolamide—Headache—Etoposide—brain cancer	0.000754	0.00136	CcSEcCtD
Brinzolamide—Nausea—Etoposide—brain cancer	0.000715	0.00129	CcSEcCtD
